Donna E. Salzman
Expertise in
11
conditions

Dr. Donna E. Salzman

Internal Medicine
University Of Alabama Health Services Foundation PC
2000 6th Ave S, 
Birmingham, AL 
Accepting New Patients
Offers Telehealth
36 Years of Experience
Expertise in
11
conditions
University Of Alabama Health Services Foundation PC
2000 6th Ave S, 
Birmingham, AL 

Overview

Donna Salzman is a primary care provider, practicing in Internal Medicine in Birmingham, Alabama. She has been practicing medicine for over 36 years.

Dr. Salzman is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Multiple Myeloma, Acute Lymphoblastic Leukemia (ALL), and Acute Myeloblastic Leukemia without Maturation.

She is actively involved in clinical research, co-authoring 32 peer reviewed articles and participating in 5 clinical trials. Dr. Salzman is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in AL

Hospital Affiliations

University Of Alabama Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

University of Alabama Health Services Foundation PC
2000 6th Ave S, Birmingham, AL 35233

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase II Study for Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplants From Matched Related Donors
Phase II Study for Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplants From Matched Related Donors
Enrollment Status: Active_not_recruiting
Publish Date: December 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
Single Arm Phase II Study of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia (ALL) in Older Patients Using Fludarabine and Total Body Irradiation (FluTBI) Regimen
Single Arm Phase II Study of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia (ALL) in Older Patients Using Fludarabine and Total Body Irradiation (FluTBI) Regimen
Enrollment Status: Completed
Publish Date: January 12, 2024
Intervention Type: Drug, Procedure
Study Drug: Fludarabine
Study Phase: Phase 2
Phase II Clinical Trial of the Use of Post-Transplant Cyclophosphamide for Graft Versus Host Disease (GvHD) Prophylaxis Following Matched Unrelated Donor (MUD) and Mismatched Unrelated Donor (MMUD)Hematopoietic Stem Cell Transplant (HSCT)
Phase II Clinical Trial of the Use of Post-Transplant Cyclophosphamide for Graft Versus Host Disease (GvHD) Prophylaxis Following Matched Unrelated Donor (MUD) and Mismatched Unrelated Donor (MMUD)Hematopoietic Stem Cell Transplant (HSCT)
Enrollment Status: Completed
Publish Date: September 30, 2022
Intervention Type: Drug
Study Drug: Cyclophosphamide
Study Phase: Phase 2
Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT)
Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT)
Enrollment Status: Completed
Publish Date: April 25, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 3 Less Clinical Trials

32 Total Publications

Post-transplant hypomethylating agents plus venetoclax maintenance improves survival in high-risk myeloid malignancies: A matched cohort study.
Post-transplant hypomethylating agents plus venetoclax maintenance improves survival in high-risk myeloid malignancies: A matched cohort study.
Journal: Blood cancer journal
Published: April 15, 2026
Similar Doctors
Expertise in
21
conditions
Dr. Cora E. Lewis
Internal Medicine
Expertise in
21
conditions
Dr. Cora E. Lewis
Internal Medicine

Office

1717 11th Ave S Ste 614, 
Birmingham, AL 
 (1.0 miles away)
205-934-6383
Languages Spoken:
English

Cora Lewis is a primary care provider, practicing in Internal Medicine in Birmingham, Alabama. Dr. Lewis is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Osteoarthritis, Obesity, Arthritis, Hormone Replacement Therapy (HRT), and Knee Replacement.

Expertise in
18
conditions
Dr. Monika M. Safford
Internal Medicine
Expertise in
18
conditions
Dr. Monika M. Safford
Internal Medicine
Before you request

Office

1717 11th Ave S, 
Birmingham, AL 
 (0.6 miles away)
205-934-6883
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Monika Safford is a primary care provider, practicing in Internal Medicine in Birmingham, Alabama. Dr. Safford is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Stroke, Coronary Heart Disease, Heart Failure, Knee Replacement, and Liver Transplant. Dr. Safford is currently accepting new patients.

Expertise in
5
conditions
Dr. Jane R. Schwebke
Internal Medicine
Expertise in
5
conditions
Dr. Jane R. Schwebke
Internal Medicine

University Of Alabama Hospital

619 19th St S, 
Birmingham, AL 
 (0.2 miles away)
205-934-6600
Languages Spoken:
English
See accepted insurances

Jane Schwebke is a primary care provider, practicing in Internal Medicine in Birmingham, Alabama. Dr. Schwebke is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Trichomoniasis, Vaginal Yeast Infection, Vulvovaginitis, and Urethritis.

Frequently Asked Questions about Dr. Donna E. Salzman

How do I make an appointment with Dr. Donna E. Salzman?

You can book an appointment with Dr. Donna E. Salzman by calling their office at 205-975-2236. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Donna E. Salzman a top-rated expert for Acute Myeloid Leukemia (AML)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Donna E. Salzman is classified as an Distinguished expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Donna E. Salzman specialize in?

While Dr. Donna E. Salzman is a Internal Medicine, they have specific expertise in Acute Myeloid Leukemia (AML), Multiple Myeloma, and Acute Lymphoblastic Leukemia (ALL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Donna E. Salzman participate in research or clinical trials?

Yes. Dr. Donna E. Salzman has published 32 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Dr. Donna E. Salzman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Donna E. Salzman accept my insurance?

Dr. Donna E. Salzman accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 205-975-2236 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Salzman's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 32 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile